A new skin care product that kills a potentially deadly bacteria could soon be available in the UK, as the UK Government looks to improve its control of the spread of the virus.
ZoSkin, a facial cleanser formulated with an enzyme that kills bacteria, has been approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for use in the NHS.
The product, which is currently undergoing clinical trials, has already been tested on patients in the United States.
Its use in Britain has also been approved, but only in a limited setting in the country.
ZooSkin is the product of a collaboration between the UK Department of Health and the UK Skin Foundation, the body which administers the cosmetics market.
The company has applied for the approval from the MHRA, which has said that the product’s use in England and Wales is in “advanced clinical testing”.
In the UK alone, more than 200 people have been diagnosed with the coronavirus.
In the United Kingdom, it has also spread to people in the Netherlands, France, Sweden and Finland.
Since the coronatavirus was first detected in March, more people have died in the US than in the whole of Europe, according to the World Health Organization.
Health experts have warned that the coronas can spread rapidly, leading to hospitalisations, seizures and even deaths.